Profile data is unavailable for this security.
About the company
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.
- Revenue in USD (TTM)610.66m
- Net income in USD-84.23m
- Incorporated1998
- Employees2.10k
- LocationNeogenomics Inc9490 Neogenomics WayFORT MYERS 33912United StatesUSA
- Phone+1 (239) 768-0600
- Fax+1 (775) 329-0852
- Websitehttps://neogenomics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brookdale Senior Living, Inc. | 3.05bn | -174.03m | 1.30bn | 25.20k | -- | 3.46 | 7.28 | 0.4253 | -0.7717 | -0.7717 | 13.50 | 1.94 | 0.533 | -- | 59.56 | 120,849.10 | -3.05 | -2.20 | -3.45 | -2.48 | 25.07 | 21.71 | -5.72 | -4.40 | -- | 0.1681 | 0.9124 | -- | 6.74 | -7.82 | 20.73 | -- | -12.60 | -- |
| Alignment Healthcare Inc | 2.01bn | -157.25m | 1.51bn | 1.54k | -- | 11.50 | -- | 0.7484 | -0.837 | -0.837 | 10.73 | 0.6849 | 2.89 | -- | 13.87 | 1,310,596.00 | -22.56 | -- | -45.76 | -- | 10.61 | -- | -7.82 | -- | -- | -6.19 | 0.551 | -- | 27.16 | -- | 1.02 | -- | -- | -- |
| US Physical Therapy Inc | 611.97m | 17.62m | 1.55bn | 3.90k | 83.46 | 3.22 | 28.94 | 2.53 | 1.23 | 1.23 | 41.69 | 31.84 | 0.6492 | -- | 8.07 | 156,955.10 | 3.97 | 7.13 | 5.61 | 10.64 | 19.45 | 21.96 | 6.11 | 9.71 | -- | 32.56 | 0.1785 | 58.53 | 9.34 | 5.91 | -38.01 | 1.78 | 5.26 | 13.33 |
| Veracyte Inc | 375.47m | -68.18m | 1.59bn | 815.00 | -- | 1.42 | -- | 4.22 | -0.9346 | -0.9346 | 5.12 | 14.64 | 0.3186 | 7.47 | 8.15 | 460,703.10 | -5.78 | -6.33 | -6.08 | -6.69 | 68.54 | 67.10 | -18.16 | -20.99 | 4.69 | -- | 0.00009 | -- | 21.76 | 31.45 | -103.51 | -- | 39.67 | -- |
| National HealthCare Corporation | 1.17bn | 81.29m | 1.63bn | 13.12k | 20.09 | 1.76 | 13.26 | 1.39 | 5.26 | 5.26 | 75.85 | 60.05 | 0.9046 | 106.16 | 10.22 | 89,092.20 | 6.21 | 5.12 | 7.33 | 6.21 | 37.76 | 39.84 | 6.86 | 6.28 | 1.99 | -- | 0.00 | 49.35 | 5.14 | 3.09 | 197.61 | 2.03 | -1.29 | 3.43 |
| NeoGenomics, Inc. | 610.66m | -84.23m | 1.75bn | 2.10k | -- | 1.89 | -- | 2.87 | -0.6698 | -0.6698 | 4.86 | 7.25 | 0.3646 | 15.88 | 4.69 | 290,791.90 | -5.03 | -3.57 | -5.29 | -3.80 | 41.80 | 41.09 | -13.79 | -9.36 | 7.22 | -- | 0.3685 | -- | 16.07 | 16.41 | 39.02 | -- | 14.98 | -- |
| Addus Homecare Corporation | 1.09bn | 65.67m | 1.88bn | 6.06k | 28.53 | 2.59 | 23.55 | 1.73 | 4.02 | 4.02 | 66.67 | 44.30 | 1.12 | -- | 9.45 | 179,534.30 | 6.75 | 5.18 | 7.82 | 6.04 | 32.12 | 30.88 | 6.04 | 4.96 | -- | 10.02 | 0.1205 | 0.00 | 11.31 | 15.43 | 35.83 | 30.83 | 12.06 | -- |
| Teladoc Health Inc | 2.62bn | -233.03m | 1.91bn | 5.60k | -- | 0.8314 | 14.42 | 0.7277 | -1.40 | -1.40 | 15.80 | 13.52 | 0.607 | 19.58 | 12.18 | 467,732.50 | -5.40 | -33.54 | -5.93 | -34.63 | 70.81 | 68.59 | -8.90 | -171.39 | 3.74 | -- | 0.4021 | -- | 8.13 | 44.16 | 98.39 | -- | 79.43 | -- |
| Brightspring Health Services Inc | -100.00bn | -100.00bn | 1.93bn | 35.00k | -- | 1.23 | -- | -- | -- | -- | -- | 9.16 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 17.75 | -- | -0.6289 | 0.9631 | -- | 0.6229 | -- | 14.32 | 28.33 | -186.80 | -- | 17.24 | -- |
| Astrana Health Inc | 1.45bn | 62.42m | 2.03bn | 1.80k | 31.27 | 3.01 | 25.08 | 1.39 | 1.32 | 1.32 | 30.85 | 13.77 | 1.31 | -- | 8.64 | 807,652.30 | 5.61 | 7.09 | 6.61 | 9.39 | 16.58 | 18.30 | 4.28 | 6.36 | -- | 61.71 | 0.4635 | 10.54 | 21.19 | 21.68 | 34.42 | 41.16 | 89.42 | -- |
| Privia Health Group Inc | 1.69bn | 18.74m | 2.07bn | 1.10k | 115.68 | 3.57 | 83.92 | 1.23 | 0.1502 | 0.1502 | 13.51 | 4.86 | 1.77 | -- | 5.56 | 1,530,584.00 | 1.85 | -- | 3.20 | -- | 9.67 | 9.15 | 1.05 | -2.56 | -- | -- | 0.00 | -- | 22.19 | 20.31 | 368.83 | -- | -12.48 | -- |
| Lifestance Health Group Inc | 1.10bn | -173.12m | 2.13bn | 6.87k | -- | 1.49 | -- | 1.93 | -0.4671 | -0.4671 | 2.97 | 3.74 | 0.5175 | -- | 7.50 | 118,339.20 | -8.12 | -- | -8.93 | -- | -- | -- | -15.69 | -- | -- | -4.69 | 0.1652 | -- | 22.82 | -- | 13.59 | -- | -- | -- |
| Evolent Health Inc | 2.18bn | -141.23m | 2.46bn | 4.70k | -- | 2.32 | -- | 1.13 | -1.25 | -1.25 | 19.28 | 10.72 | 0.8316 | -- | 6.30 | 462,948.70 | -4.22 | -9.60 | -5.36 | -12.59 | 20.56 | 24.50 | -5.07 | -13.66 | -- | -0.0548 | 0.3272 | -- | 45.26 | 25.65 | -660.71 | -- | -6.18 | -- |
| Progyny Inc | 1.11bn | 61.26m | 2.57bn | 563.00 | 44.39 | 4.53 | 40.28 | 2.32 | 0.6071 | 0.6071 | 10.98 | 5.95 | 1.53 | -- | 3.63 | 1,968,529.00 | 8.48 | 11.50 | 11.88 | 16.02 | 21.89 | 21.48 | 5.53 | 6.64 | -- | -- | 0.00 | 0.00 | 38.34 | 59.52 | 104.35 | -- | 44.47 | -- |
| Agilon Health Inc | 4.78bn | -207.85m | 2.59bn | 1.12k | -- | 3.76 | -- | 0.5415 | -0.5182 | -0.71 | 11.78 | 1.68 | 2.13 | -- | 3.71 | 4,283,411.00 | -9.27 | -- | -20.91 | -- | 6.37 | -- | -4.35 | -- | -- | -- | 0.0514 | -- | 80.74 | -- | -112.01 | -- | -- | -- |
Data as of May 31 2024. Currency figures normalised to Neogenomics Inc's reporting currency: US Dollar USD
58.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 18.42m | 14.43% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 13.98m | 10.95% |
| Brown Advisory LLCas of 31 Mar 2024 | 9.67m | 7.57% |
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 6.86m | 5.37% |
| Janus Henderson Investors US LLCas of 31 Mar 2024 | 6.22m | 4.87% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 4.90m | 3.84% |
| Greenhouse Funds LLLPas of 31 Mar 2024 | 4.40m | 3.44% |
| Macquarie Investment Management Business Trustas of 31 Mar 2024 | 4.02m | 3.15% |
| First Light Asset Management LLCas of 31 Mar 2024 | 3.30m | 2.59% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 3.11m | 2.43% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
